PedAM
Pediatric Disease Annotations & Medicines
| Disease | wegener granulomatosis |
| Phenotype | C0003864|arthritis |
| Sentences | 3 |
| PubMedID- 23115803 | Rituximab is a chimeric murine/human monoclonal antibody (mab) that targets the cd20 antigen (also known as membrane-spanning 4-domains, subfamily a, member 1, or ms4a1) and has been approved by the united states food and drug administration for the treatment of non-hodgkins lymphomas (nhl; diffused large-b cell, low-grade, or follicular types), rheumatoid arthritis, granulomatosis with polyangiitis (wegener's granulomatosis) and microscopic polyangiitis. |
| PubMedID- 23115808 | Rituximab is a chimeric murine/human monoclonal antibody (mab) that targets the cd20 antigen (also known as membrane-spanning 4-domains, subfamily a, member 1; or ms4a1), which is expressed on 95% of the transformed b-cells that participate in the pathogenesis of non-hodgkin lymphomas (nhl; diffused large-b cell, low-grade, or the follicular types), a hematological malignancy, and autoimmune diseases such as rheumatoid arthritis (ra), granulomatosis with polyangiitis (wegener's granulomatosis), and microscopic polyangiitis. |
| PubMedID- 23384023 | A very rare case of etanercept-induced wegener's granulomatosis in a patient with long-standing rheumatoid arthritis is reported. |
Page: 1